Health-system pharmacists' role in immunizing adults against pneumococcal disease and influenza

被引:16
作者
Grabenstein, JD [1 ]
Bonasso, J
机构
[1] USA Med Command, Falls Church, VA USA
[2] Univ Michigan Hlth Syst, Web Serv Grp, Ann Arbor, MI USA
关键词
contraindications; dosage; dosage schedules; health professions; immunization; influenza vaccines; interventions; patient information; pharmaceutical care; pharmacists; institutional; pharmacy; pneumococcal vaccines; toxicity; vaccines;
D O I
10.1093/ajhp/56.suppl_2.S3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of pharmacists in immunizing adults against pneumococcal disease and influenza is discussed. Pneumococcal disease and influenza each cause up to 40,000 deaths annually in the United States. Vaccination against these diseases is encouraged for all people 65 years of age or older and for those with certain chronic diseases or immunosuppression. Influenza virus vaccine should also be given to residents of long-term-care facilities, many pregnant women, and health care workers. Pneumococcal vaccine is usually given once in a lifetime; influenza virus vaccine is given annually in the fall. Advocacy of immunization is consistent with the precepts of pharmaceutical care, and pharmacists can promote immunization by assuming the roles of educator, facilitator, and immunizer. Despite lack of specific mention of it in accreditation standards, health-system personnel have a duty to vaccinate adults, just as they do pediatric patients. Pharmacists should review immunization records with patients periodically and at the time of immunization. As with other drug products, formulary decisions and the distribution, storage, and handling of vaccines are important pharmacist responsibilities. Pharmacoeconomic studies have demonstrated the value of pneumococcal and influenza virus vaccines. Medicare covers these vaccines under Part B. Pharmacists have an important role to play in promoting adult immunizations against pneumococcal disease and influenza.
引用
收藏
页码:S3 / S24
页数:22
相关论文
共 57 条
[41]   INFLUENZA VACCINATION PROGRAMS FOR ELDERLY PERSONS - COST-EFFECTIVENESS IN A HEALTH MAINTENANCE ORGANIZATION [J].
MULLOOLY, JP ;
BENNETT, MD ;
HORNBROOK, MC ;
BARKER, WH ;
WILLIAMS, WW ;
PATRIARCA, PA ;
RHODES, PH .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) :947-952
[42]  
*NAT COAL AD IMM, 1998, CALL ACT IMPR INFL P
[43]  
*NAT CTR HLTH SERV, 1971, J AM PHARM ASS NS, V11, P482
[44]   THE EFFECTIVENESS OF VACCINATION AGAINST INFLUENZA IN HEALTHY, WORKING ADULTS [J].
NICHOL, KL ;
LIND, A ;
MARGOLIS, KL ;
MURDOCH, M ;
MCFADDEN, R ;
HAUGE, M ;
MAGNAN, S ;
DRAKE, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (14) :889-893
[45]   THE EFFICACY AND COST-EFFECTIVENESS OF VACCINATION AGAINST INFLUENZA AMONG ELDERLY PERSONS LIVING IN THE COMMUNITY [J].
NICHOL, KL ;
MARGOLIS, KL ;
WUORENMA, J ;
VONSTERNBERG, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (12) :778-784
[46]  
*OCC SAF HLTH ADM, 1996, OSHA REQ HEP B VACC
[47]  
Pau AK, 1996, PHARMACOTHERAPY, V16, P163
[48]  
PETER G, 1997, RED BOOK REPORT COMM
[49]   Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients [J].
Potter, J ;
Stott, DJ ;
Roberts, MA ;
Elder, AG ;
ODonnell, B ;
Knight, PV ;
Carman, WF .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) :1-6
[50]   FACTORS AFFECTING OUTCOMES OF MEDICATION-HISTORY INTERVIEWING BY PHARMACY STUDENTS [J].
RANELLI, PL ;
SVARSTAD, BL ;
BOH, L .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (02) :267-281